<?xml version='1.0' encoding='utf-8'?>
<document id="28917081"><sentence text="Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats."><entity charOffset="39-47" id="DDI-PubMed.28917081.s1.e0" text="tramadol" /></sentence><sentence text="Tramadol is prone to be abused alone, or in combination with 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)"><entity charOffset="0-8" id="DDI-PubMed.28917081.s2.e0" text="Tramadol" /><entity charOffset="61-94" id="DDI-PubMed.28917081.s2.e1" text="3,4-methylenedioxymethamphetamine" /><entity charOffset="96-100" id="DDI-PubMed.28917081.s2.e2" text="MDMA" /><pair ddi="false" e1="DDI-PubMed.28917081.s2.e0" e2="DDI-PubMed.28917081.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28917081.s2.e0" e2="DDI-PubMed.28917081.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s2.e0" e2="DDI-PubMed.28917081.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28917081.s2.e1" e2="DDI-PubMed.28917081.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s2.e1" e2="DDI-PubMed.28917081.s2.e2" /></sentence><sentence text=" It was reported that 95% of people with a history of substance abuse in the United States used tramadol in 2004"><entity charOffset="96-104" id="DDI-PubMed.28917081.s3.e0" text="tramadol" /></sentence><sentence text=" According to the WHO report in 2016, there was a growing number of tramadol abusers alone or in combination with psychoactive substances such as MDMA in particular in some Middle East countries"><entity charOffset="68-76" id="DDI-PubMed.28917081.s4.e0" text="tramadol" /><entity charOffset="146-153" id="DDI-PubMed.28917081.s4.e1" text="MDMA" /><pair ddi="false" e1="DDI-PubMed.28917081.s4.e0" e2="DDI-PubMed.28917081.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28917081.s4.e0" e2="DDI-PubMed.28917081.s4.e1" /></sentence><sentence text=" Higher concentrations of tramadol in plasma may lead to adverse drug reactions or lethal intoxication"><entity charOffset="26-34" id="DDI-PubMed.28917081.s5.e0" text="tramadol" /></sentence><sentence text=" In this study, the effect of MDMA on the pharmacokinetics of tramadol was examined in male rats"><entity charOffset="62-70" id="DDI-PubMed.28917081.s6.e0" text="tramadol" /><entity charOffset="30-37" id="DDI-PubMed.28917081.s6.e1" text="MDMA" /><pair ddi="false" e1="DDI-PubMed.28917081.s6.e1" e2="DDI-PubMed.28917081.s6.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s6.e1" e2="DDI-PubMed.28917081.s6.e0" /></sentence><sentence text="" /><sentence text="The effect of MDMA on Tmax, Cmax, area under the curve, elimination rate, and half-life of tramadol and its metabolites was examined"><entity charOffset="91-99" id="DDI-PubMed.28917081.s8.e0" text="tramadol" /><entity charOffset="14-21" id="DDI-PubMed.28917081.s8.e1" text="MDMA" /><pair ddi="false" e1="DDI-PubMed.28917081.s8.e1" e2="DDI-PubMed.28917081.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s8.e1" e2="DDI-PubMed.28917081.s8.e0" /></sentence><sentence text=" Two control and two treatment groups were designed" /><sentence text=" The treatment groups received MDMA 18 h before the administration of tramadol"><entity charOffset="70-78" id="DDI-PubMed.28917081.s10.e0" text="tramadol" /><entity charOffset="31-38" id="DDI-PubMed.28917081.s10.e1" text="MDMA" /><pair ddi="false" e1="DDI-PubMed.28917081.s10.e1" e2="DDI-PubMed.28917081.s10.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s10.e1" e2="DDI-PubMed.28917081.s10.e0" /></sentence><sentence text=" Jugular vein blood samples were analyzed by high-performance liquid chromatography with fluorescent detector to determine the concentrations of tramadol and its metabolites"><entity charOffset="145-153" id="DDI-PubMed.28917081.s11.e0" text="tramadol" /></sentence><sentence text=" Independent-sample t-test was used to define the differences between pharmacokinetic parameters of control and treatment groups" /><sentence text="" /><sentence text="When tramadol administered intraperitoneally, the absorption rate of this drug was reduced, and a lower Cmax (40%) with longer Tmax (eight-fold) was achieved"><entity charOffset="5-13" id="DDI-PubMed.28917081.s14.e0" text="tramadol" /></sentence><sentence text=" MDMA exerted greater inhibitory effects on cytochrome P450 3A4 (CYP3A4) than on cytochrome P450 2D6 (CYP2D6)"><entity charOffset="1-8" id="DDI-PubMed.28917081.s15.e0" text="MDMA" /></sentence><sentence text=" The M2 metabolite ratio was reduced by half, and because of the inhibition of M2 production, the M1 plasma concentration slightly increased" /><sentence text="" /><sentence text="According to the obtained data, MDMA treatment affected the absorption, distribution and metabolism phases of tramadol"><entity charOffset="110-118" id="DDI-PubMed.28917081.s18.e0" text="tramadol" /><entity charOffset="32-39" id="DDI-PubMed.28917081.s18.e1" text="MDMA" /><pair ddi="false" e1="DDI-PubMed.28917081.s18.e1" e2="DDI-PubMed.28917081.s18.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s18.e1" e2="DDI-PubMed.28917081.s18.e0" /></sentence><sentence text=" This treatment increased the concentration of tramadol if administered intravenously and can latent the absorption of tramadol in oral route"><entity charOffset="47-55" id="DDI-PubMed.28917081.s19.e0" text="tramadol" /><entity charOffset="119-127" id="DDI-PubMed.28917081.s19.e1" text="tramadol" /><pair ddi="false" e1="DDI-PubMed.28917081.s19.e0" e2="DDI-PubMed.28917081.s19.e0" /><pair ddi="false" e1="DDI-PubMed.28917081.s19.e0" e2="DDI-PubMed.28917081.s19.e1" /></sentence><sentence text=" However, MDMA was introduced as CYP2D6 inhibitor; in this study, MDMA inhibited CYP3A4 isoenzymes as well"><entity charOffset="10-17" id="DDI-PubMed.28917081.s20.e0" text="MDMA" /><entity charOffset="66-73" id="DDI-PubMed.28917081.s20.e1" text="MDMA" /><pair ddi="false" e1="DDI-PubMed.28917081.s20.e0" e2="DDI-PubMed.28917081.s20.e0" /><pair ddi="false" e1="DDI-PubMed.28917081.s20.e0" e2="DDI-PubMed.28917081.s20.e1" /></sentence><sentence text=" This finding is important for the compounds that are metabolized through CYP3A4" /><sentence text=" It can be proposed that in abusers of MDMA who only receive tramadol for medical or nonmedical purposes in short intervals, the dangers of the intravenous administration of tramadol should be considered, and if tramadol is administered orally, the desired effect may not be achieved at the routine dose"><entity charOffset="61-69" id="DDI-PubMed.28917081.s22.e0" text="tramadol" /><entity charOffset="174-182" id="DDI-PubMed.28917081.s22.e1" text="tramadol" /><entity charOffset="212-220" id="DDI-PubMed.28917081.s22.e2" text="tramadol" /><entity charOffset="39-46" id="DDI-PubMed.28917081.s22.e3" text="MDMA" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e3" e2="DDI-PubMed.28917081.s22.e3" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e3" e2="DDI-PubMed.28917081.s22.e0" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e3" e2="DDI-PubMed.28917081.s22.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e3" e2="DDI-PubMed.28917081.s22.e2" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e0" e2="DDI-PubMed.28917081.s22.e0" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e0" e2="DDI-PubMed.28917081.s22.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e0" e2="DDI-PubMed.28917081.s22.e2" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e1" e2="DDI-PubMed.28917081.s22.e1" /><pair ddi="false" e1="DDI-PubMed.28917081.s22.e1" e2="DDI-PubMed.28917081.s22.e2" /></sentence><sentence text="" /></document>